ULYM18040 / DLBCL / Carla Casulo
Research Question:
What is the correlation between an adapted PET scan and residual cancer cells, as
measured by circulating tumor DNA in patients with early stage diffuse large B cell
lymphoma?
Basic Study Information
Purpose:
The overarching goals of this study are to measure levels of circulating tumor DNA
(ctDNA) in patients with early stage diffuse large B cell lymphoma (DLBCL), to assess
the change in ctDNA during treatment in order to prospectively identify markers of
treatment failure, and to use ctDNA as a future tool for response adapted therapy.
Location: University of Rochester Medical Center
Study Reference #: ULYM18040
Lead Researcher (Principal Investigator)
Lead Researcher:
Carla Casulo
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search